430 related articles for article (PubMed ID: 11456453)
21. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
Yu Z; Xing Y
Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
[TBL] [Abstract][Full Text] [Related]
22. Smad6 inhibits signalling by the TGF-beta superfamily.
Imamura T; Takase M; Nishihara A; Oeda E; Hanai J; Kawabata M; Miyazono K
Nature; 1997 Oct; 389(6651):622-6. PubMed ID: 9335505
[TBL] [Abstract][Full Text] [Related]
23. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
Böttinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM
EMBO J; 1997 May; 16(10):2621-33. PubMed ID: 9184209
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair.
Munz B; Smola H; Engelhardt F; Bleuel K; Brauchle M; Lein I; Evans LW; Huylebroeck D; Balling R; Werner S
EMBO J; 1999 Oct; 18(19):5205-15. PubMed ID: 10508154
[TBL] [Abstract][Full Text] [Related]
25. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells.
Kelley TJ; Elmer HL; Corey DA
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):732-8. PubMed ID: 11726399
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells.
Yanagisawa K; Osada H; Masuda A; Kondo M; Saito T; Yatabe Y; Takagi K; Takahashi T; Takahashi T
Oncogene; 1998 Oct; 17(13):1743-7. PubMed ID: 9796704
[TBL] [Abstract][Full Text] [Related]
27. Involvement of Smads in TGFbeta1-induced furin (fur) transcription.
Blanchette F; Rudd P; Grondin F; Attisano L; Dubois CM
J Cell Physiol; 2001 Aug; 188(2):264-73. PubMed ID: 11424093
[TBL] [Abstract][Full Text] [Related]
28. Smad2 role in mesoderm formation, left-right patterning and craniofacial development.
Nomura M; Li E
Nature; 1998 Jun; 393(6687):786-90. PubMed ID: 9655392
[TBL] [Abstract][Full Text] [Related]
29. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22.
Honma M; Minami-Hori M; Takahashi H; Iizuka H
J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341
[TBL] [Abstract][Full Text] [Related]
30. Suppression of keratin 15 expression by transforming growth factor beta in vitro and by cutaneous injury in vivo.
Werner S; Munz B
Exp Cell Res; 2000 Jan; 254(1):80-90. PubMed ID: 10623468
[TBL] [Abstract][Full Text] [Related]
31. Functional significance of Smad2 in regulating basal keratinocyte migration during wound healing.
Hosokawa R; Urata MM; Ito Y; Bringas P; Chai Y
J Invest Dermatol; 2005 Dec; 125(6):1302-9. PubMed ID: 16354202
[TBL] [Abstract][Full Text] [Related]
32. Activin A induces neuronal differentiation and survival via ALK4 in a SMAD-independent manner in a subpopulation of human neuroblastomas.
Suzuki K; Kobayashi T; Funatsu O; Morita A; Ikekita M
Biochem Biophys Res Commun; 2010 Apr; 394(3):639-45. PubMed ID: 20226172
[TBL] [Abstract][Full Text] [Related]
33. Altered epidermal cell growth control in vivo by inducible expression of transforming growth factor beta 1 in the skin of transgenic mice.
Fowlis DJ; Cui W; Johnson SA; Balmain A; Akhurst RJ
Cell Growth Differ; 1996 May; 7(5):679-87. PubMed ID: 8732677
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta type II receptors and smad proteins in follicular thyroid tumors.
West J; Munoz-Antonia T; Johnson JG; Klotch D; Muro-Cacho CA
Laryngoscope; 2000 Aug; 110(8):1323-7. PubMed ID: 10942134
[TBL] [Abstract][Full Text] [Related]
35. Expression of Smad1 and Smad2 during embryogenesis suggests a role in organ development.
Dick A; Risau W; Drexler H
Dev Dyn; 1998 Apr; 211(4):293-305. PubMed ID: 9566949
[TBL] [Abstract][Full Text] [Related]
36. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
Amendt C; Schirmacher P; Weber H; Blessing M
Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
[TBL] [Abstract][Full Text] [Related]
37. Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation.
Rosendahl A; Checchin D; Fehniger TE; ten Dijke P; Heldin CH; Sideras P
Am J Respir Cell Mol Biol; 2001 Jul; 25(1):60-8. PubMed ID: 11472976
[TBL] [Abstract][Full Text] [Related]
38. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.
Xie W; Mertens JC; Reiss DJ; Rimm DL; Camp RL; Haffty BG; Reiss M
Cancer Res; 2002 Jan; 62(2):497-505. PubMed ID: 11809701
[TBL] [Abstract][Full Text] [Related]
39. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K
Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
